India's Bharat Biotech says its Covaxin booster dose offers long term protection

Coronavirus disease (COVID-19) vaccination drive for children aged 15-18 in Mumbai

(Reuters) - India’s Bharat Biotech said on Saturday a booster dose of its COVID-19 vaccine Covaxin offered long-term protection from severe disease in a trial.

The company said a booster dose was given to trial participants six months after they received their second dose.

(Reporting by Rhea Binoy in Bengaluru; Editing by Toby Chopra)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting